Table 4.
Method | Descriptor | Target | NO AD | WITH AD | |||||
---|---|---|---|---|---|---|---|---|---|
R2 | RMSE | Spearman ρ |
R2 | RMSE | Spearman ρ |
Coverage | |||
RF | SiRMS |
CHK1 (n = 1215) |
0.64 | 0.77 | 0.78 | 0.72 | 0.66 | 0.85 | 75% |
SVM | Dragon | 0.64 | 0.76 | 0.77 | 0.65 | 0.73 | 0.81 | 72% | |
QSAR_CONSENSUS | 0.67 | 0.74 | 0.79 | 0.68 | 0.71 | 0.83 | 87% | ||
RF | SiRMS |
ERK2 (n = 48) |
0.71 | 0.62 | 0.80 | 0.69 | 0.56 | 0.79 | 75% |
SVM | Dragon | 0.62 | 0.68 | 0.77 | 0.59 | 0.65 | 0.72 | 73% | |
QSAR_CONSENSUS | 0.69 | 0.62 | 0.79 | 0.67 | 0.59 | 0.76 | 90% | ||
RF | SiRMS |
UK (n = 668) |
0.69 | 0.66 | 0.85 | 0.77 | 0.53 | 0.89 | 75% |
SVM | Dragon | 0.68 | 0.72 | 0.84 | 0.70 | 0.64 | 0.86 | 71% | |
QSAR_CONSENSUS | 0.71 | 0.68 | 0.87 | 0.73 | 0.61 | 0.88 | 88% |